Since introducing the first Laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide.
Nanoscope Therapeutics publishes clinical results of MCO-010 findings for patients with retinitis pigmentosa
The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.
Higher Molar Dose and Its Translation into Clinical Practice
Moorfields Eye Hospital INSIGHT research hub will collaborate with artificial intelligence development company Insitro
The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases
Phase 3 COAST trial fails to meet primary endpoints for wet AMD, Opthea reports
The Combination OPT-302 with Aflibercept Study (COAST) evaluated sozinibercept 2 mg in combination with aflibercept 2 mg for wet age-related macular degeneration
Study examines real-world treat-and-extend outcomes and background factors of macular atrophy
The study demonstrated that the number of injections needed gradually decreased during the follow-up period
Increased paediatric astigmatism prevalence and severity after COVID-19
The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms